Fourth Quarter Revenue: $198 million, 18% year-over-year increase, 14% organic growth. Full Year Revenue: $738 million, 16% growth on both reported and organic non-COVID basis. Gross Margin: Fourth ...
WALTHAM, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its ...
Repligen ((RGEN)) has held its Q4 earnings call. Read on for the main highlights of the call. Repligen’s latest earnings call struck a notably upbeat tone, with management highlighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results